CONGRESS GUIDE

Recommendations

Info

ERS International Congress 2016 DETAILED PROGRAMME MONDAY 05 SEPTEMBER, 2016 Aims : The session will provide an updated overview of the main achievements of the basic research on pleural empyema that are relevant for clinicians. In particular, the key benefits of the modern therapeutic procedures for pleural empyema, which are largely based on videoassisted technology (VAT), will be described. The take-home message will be that depending on the disease stage, optimal engagement between pulmonologists and surgeons is essential. The main pitfalls that relate to this disease will also be presented to facilitate recognition of the underlying diseases, as those diseases may not always be obvious at first. Track(s) : Infection Intensive care Tag(s) : Translational Target audience : Physiotherapist, Respiratory physician, Resident, Pulmonologist, Thoracic surgeon Chairs : Danail Petrov (Sofia, Bulgaria), Hans-Beat Ris (LAUSANNE, Switzerland) 08:30 09:00 09:30 New insights into an old disease Gernot G.U. Rohde (Maastricht, Netherlands) How to prevent progression to stage III disease Philippe Astoul (Marseille, France) The changing spectrum of surgical solutions: video-assisted thoracic surgery (VATS), robotics, and open surgery Didier Lardinois (Basel, Switzerland) 1755 1756 1757 10:00 Major pitfalls in pleural empyema: what about the underlying disease? Dragan R. Subotic (Belgrade, Republic of Serbia) Platinum Room 1+2 Session 326 08:30 - 10:30 Symposium: Diagnosing primary ciliary dyskinesia (PCD) in a molecular age Aims : The aims of this session are to explain the importance of an accurate diagnosis from the patients’ perspective; describe the barriers to obtaining a diagnosis for this rare ‘orphan’ lung disease; present data from an international survey of >300 patients conducted as part of the PCD task force; describe the clinical features that should prompt referral for diagnostic testing; discuss the disparity of diagnostic services in Europe; explain the pathophysiology and genetic basis of PCD; and present the recommendations of the ERS PCD task force "Diagnosis of primary ciliary dyskinesia (PCD) in a molecular age: A practice guideline for diagnosing patients with PCD." Track(s) : Paediatric Tag(s) : Clinical Target audience : Allied health professional, Clinician, Fellow, General practitioner, Junior member, Lung function technician, Neonatologist, Nurse, Otolaryngologist, Paediatrician, Pathologist, Patient, Physiotherapist, Pulmonologist, Researcher, Resident, Respiratory physician, Respiratory therapist, Scientist, Trainee Chairs : Andrew Bush (LONDON, United Kingdom), Angelo Barbato (Padova, PD, Italy) 1758 08:30 09:00 09:30 Patients’ perspectives on diagnostic testing Fiona Copeland (Milton Keynes, United Kingdom) Barriers and solutions to accurate diagnoses Claudia Kuehni (Bern, Switzerland) Genetic mechanisms of PCD Heymut Omran (Münster, Germany) 1759 1760 1761 10:00 ERS PCD task force recommendations for diagnostic testing Jane Lucas (Southampton, United Kingdom) Platinum Room 3+4 Session 327 08:30 - 10:30 Oral Presentation: New and old therapies for chronic lung diseases Chairs : Philippe Camus (DIJON, France), Alfredo Chetta (PARMA (PR), Italy) 1762 OA1763 OA1766 LATE-BREAKING ABSTRACT: Blood eosinophils (EOS) are a biomarker of COPD exacerbation reduction with inhaled corticosteroids (ICS): An across-trials model-based approach Neil C. Barnes (London, United Kingdom), Salman H. Siddiqui, Ian Pavord, Neil C. Barnes, Sally Lettis, Alessandro Guasconi, Stefano Petruzzelli Protective effects of vitamin D supplementation against acute respiratory infection are greatest in those with the lowest baseline vitamin D status Adrian R Martineau (London, United Kingdom), Adrian R. Martineau, David A. Jolliffe, Richard L. Hooper, Lauren Greenberg, John F. Aloia, Peter Bergman, Gal Dubnov-Raz, Susanna Esposito, Davaasambuu Ganmaa, Emma C. Goodall, Cameron Grant, Christopher J. Griffiths, Wim Janssens, Ilkka Laaksi, Semira Manaseki-Holland, David Murdoch, Rachel E. Neale, Judy R. Rees, Steve Simpson, Iwona Stelmach, Geeta Trilok Kumar, Mitsuyoshi Urashima, Carlos A. Camargo 124 26.08.2016
ERS International Congress 2016 DETAILED PROGRAMME MONDAY 05 SEPTEMBER, 2016 OA1764 OA1765 OA1767 OA1768 OA1769 Dose modifications and dose intensity during treatment with pirfenidone Steven Nathan (Falls Church, United States of America), Steven Nathan, Lisa Lancaster, Carlo Albera, Marilyn Glassberg, Jeffrey Swigris, Frank Gilberg, Klaus-Uwe Kirchgaessler, Ute Petzinger, Paul Noble Effect of continued pirfenidone treatment following a 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies Steven Nathan (Falls Church, United States of America), Steven Nathan, Carlo Albera, Ulrich Costabel, Ian Glaspole, Marilyn Glassberg, Lisa Lancaster, David Lederer, Carlos Pereira, Jeffrey Swigris, Andrey Pavlov, John Stauffer, Bann-Mo Day, Willis Chou, Athol Wells Correlation between change in lung density and lung function parameters in treated alpha-1 protease inhibitor (A1-PI) deficiency Helmut Teschler (ESSEN, Germany), Helmut Teschler, Niels Seersholm, Kenneth R. Chapman, Marion Wencker, Michael Fries, Oliver Vit, N. Gerard McElvaney Increased proportion of slow decliners in patients with alpha-1 protease inhibitor (A1-PI) deficiency following treatment with A1-PI Noel Gerard McElvaney (Dublin, Ireland), Noel Gerard McElvaney, Niels Seersholm, Kenneth R. Chapman, Marion Wencker, Michael Fries, Oliver Vit Effectiveness of rituximab (RTX) therapy in recurrent granulomatosis with polyangiitis (GPA) Dariusz Gawryluk (Warsaw, Poland), Dariusz Gawryluk, Justyna Fijolek, Elzbieta Wiatr OA1770 Combination of pentoxifylline and vitamin E for the treatment of sarcoidosis: Retrospective analysis Alexander Vizel (Kazan, Republic of Tatarstan, Russian Federation), Alexander Vizel, Irina Vizel Room C Session 328 08:30 - 10:30 Oral Presentation: Lung cancer immunology: latest research Chairs : Thierry Berghmans (Brussels, Belgium), Annette Fisseler-Eckhoff (Wiesbaden, Germany) Introduction talk OA1771 OA1772 OA1773 OA1775 OA6021 LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features Eva Maria Garrido-Martin (Southampton, United Kingdom), Eva Maria Garrido-Martin, Rocio Martinez-Nunez, Toby Mellows, Christian H. Ottensmeier, Pandurangan Vijayanand, Tilman Sanchez-Elsner Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA Joanna Domaga a-Kulawik (Warsaw, Poland), Joanna Domagala-Kulawik, Iwona Osinska, Dominika Wolosz, Monika Pasieka-Lis, Juliusz Pankowski Microscopic vessel invasion and visceral pleural invasion are correlated with EMT, cancer stemness and resistance to therapy in lung adenocarcinoma Shinya Neri (Kashiwa, Japan), Shinya Neri, Toshi Menju, Akihiko Yoshizawa, Terumasa Sowa, Hideki Motoyama, Kyoko Hijiya, Toyofumi Chen-Yoshikawa, Akihiro Aoyama, Toshihiko Sato, Makoto Sonobe, Hiroshi Date The prognostic influence of tumor infiltrating M1 and M2 phenotype macrophages in resected non-small cell lung cancer Jurgita Jackute (Kaunas, Lithuania), Jurgita Jackute, Marius Zemaitis, Darius Pranys, Brigita Sitkauskiene, Skaidrius Miliauskas, Raimundas Sakalauskas Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer Joanna Domaga a-Kulawik (Warsaw, Poland), Iwona Osinska, Anna Stelmaszczyk-Emmel, Malgorzata Polubiec- Kownacka, Dariusz Dziedzic, Joanna Domagala-Kulawik OA6022 Anti-cancer effects of bevacizumab and cisplatin on cancer cell invaded human ex-vivo lung tissue Sebastian Konzok (Hannover, Germany), Sebastian Konzok, Susann Dehmel, Peter Braubach, Danny Jonigk, Olaf Pfennig, Hans-Gerd Fieguth, Armin Braun, Katherina Sewald Room G Session 329 08:30 - 10:30 Oral Presentation: New genomic targets in pulmonary disease Chairs : Aurelie Fabre (Dublin, Ireland), Philippe Bonniaud (Dijon, France) OA1776 LATE-BREAKING ABSTRACT: Network-based meta-analysis of lung, sputum and blood transcriptomics in COPD Rosa Faner Canet (Barcelona, Spain), Maria Rosa Faner Canet, Jarrett Morrow, Guillaume Noell, Alejandra Lopez-Giraldo, Tamara Cruz, Ruth Tal-Singer, Bruce E. Miller, Roberto Rodríguez-Roisin, Ed K. Silverman, Alvar Agusti, Craig P. Hersh 125 26.08.2016
Page 1:
HELP SHAPE THE FUTURE OF RESPIRATOR
Page 4 and 5:
WELCOME FROM THE CONGRESS CHAIRS ER
Page 6 and 7:
ERS LONDON 2016 Data scanning syste
Page 8 and 9:
MAPS ERS LONDON 2016 ■ CONGRESS M
Page 10 and 11:
MAPS ERS LONDON 2016 ■ EXHIBITION
Page 12 and 13:
ERS MAPSWORLD VILLAGE ERS LONDON 20
Page 14 and 15:
INVITATION JOIN US AT THE OPENING C
Page 16 and 17:
CONGRESS RESOURCES AREA Te Congress
Page 18 and 19:
ERS-SPLF Joint Session Saturday 3 S
Page 20 and 21:
ERS-CTS Joint Session Saturday 3 Se
Page 22 and 23:
PROGRAMME AT A GLANCE
Page 24 and 25:
ERS International Congress 2016 OUT
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
WORLD VILLAGE SESSIONS
Page 44 and 45:
PROGRAMME DETAILS
Page 46 and 47:
ERS International Congress 2016 DET
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
ERS International Congress 2016 Roo
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
ERS International Congress 2016 T-0
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119: ERS International Congress 2016 DET
Page 144 and 145: ERS International Congress 2016 Pla
Page 148 and 149: ERS International Congress 2016 Roo
Page 166 and 167: ERS International Congress 2016 ICC
Page 182 and 183: ERS International Congress 2016 Pla
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
ERS International Congress 2016 Pla
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
ERS International Congress 2016 13:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
ERS International Congress 2016 Pla
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
ERS International Congress 2016 WOR
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
ERS International Congress 2016 IND
Page 386 and 387:
Page 388 and 389:
INDUSTRY SPONSORED SESSIONS DISCLAI
Page 390 and 391:
Page 392 and 393:
Page 394 and 395:
Page 396 and 397:
Page 398 and 399:
Page 400 and 401:
Page 402 and 403:
Page 404 and 405:
Page 406 and 407:
Page 408 and 409:
CHAIR AND COORDINATOR INDEX Name, S
Page 410 and 411:
CHAIR AND COORDINATOR INDEX S., 456
Page 412 and 413:
SPEAKER INDEX 4753, 4758, 4759 GIBS
Page 414 and 415:
SPEAKER INDEX ZAR H., 1734 ZAVORSKY
Page 416 and 417:
AUTHOR INDEX AKHTER S., PA1020, 118
Page 418 and 419:
AUTHOR INDEX ARAUJO SILVA C., PA136
Page 420 and 421:
AUTHOR INDEX 4323, 4866, 4869 BARBA
Page 422 and 423:
AUTHOR INDEX BILTON D., PA2633, PA4
Page 424 and 425:
AUTHOR INDEX BROWN M., PA5047 BROWN
Page 426 and 427:
AUTHOR INDEX PA2759 CASTIGLIA D., P
Page 428 and 429:
AUTHOR INDEX ALVAREZ B., PA1034 CIM
Page 430 and 431:
AUTHOR INDEX D’ORAZIO C., OA1489,
Page 432 and 433:
AUTHOR INDEX DEVRAJ M., PA2689 DEWA
Page 434 and 435:
AUTHOR INDEX EL ANDALOUSSI M., PA25
Page 436 and 437:
AUTHOR INDEX PA2634, PA2636, 3266,
Page 438 and 439:
AUTHOR INDEX GARCIA MOYANO M., PA23
Page 440 and 441:
AUTHOR INDEX GORHAM J., PA2820 GORI
Page 442 and 443:
AUTHOR INDEX HANIBUCHI M., PA778 HA
Page 444 and 445:
AUTHOR INDEX HOLMES L., PA4101, PA4
Page 446 and 447:
AUTHOR INDEX JADDOE V., PA3134 JADH
Page 448 and 449:
AUTHOR INDEX KANG B., PA1160, 2485
Page 450 and 451:
AUTHOR INDEX KJELDGAARD P., PA1125,
Page 452 and 453:
AUTHOR INDEX KUNA P., OA256, PA964,
Page 454 and 455:
AUTHOR INDEX PA5096 LEPEJ D., PA129
Page 456 and 457:
AUTHOR INDEX PA1311 MACEDO C., PA25
Page 458 and 459:
AUTHOR INDEX MARTÍNEZ-MEMIJE R., P
Page 460 and 461:
AUTHOR INDEX MIKURA S., PA4847 MILA
Page 462 and 463:
AUTHOR INDEX MOYA A., PA3762 MOYA A
Page 464 and 465:
AUTHOR INDEX NIKOLETOU D., PA1368 N
Page 466 and 467:
AUTHOR INDEX PA1569 OUPADIA S., PA2
Page 468 and 469:
AUTHOR INDEX OA1802, PA2083, PA2373
Page 470 and 471:
AUTHOR INDEX PPATHANASSIOU E., PA41
Page 472 and 473:
AUTHOR INDEX PA4311, PA4325 RIBEIRO
Page 474 and 475:
AUTHOR INDEX SABOGAL PINEROS Y., PA
Page 476 and 477:
AUTHOR INDEX SCHMIDT A., PA902 SCHM
Page 478 and 479:
AUTHOR INDEX SIMIDCHIEV A., PA300 S
Page 480 and 481:
AUTHOR INDEX STANCHEVA G., PA2854,
Page 482 and 483:
AUTHOR INDEX PA4357, PA4359 TAN L.,
Page 484 and 485:
AUTHOR INDEX TRIEBNER K., 629, OA49
Page 486 and 487:
AUTHOR INDEX PA601, PA1825, 2903, 3
Page 488 and 489:
AUTHOR INDEX PA3864, 4501, 4856 WAL
Page 490 and 491:
AUTHOR INDEX YAMAMOTO A., PA569, PA
show all

CONGRESS GUIDE

Create successful ePaper yourself

Delete template?

Save as template?